PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 158 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $550,000 | +15.3% | 118,587 | +4.5% | 0.22% | +1.8% |
| Q4 2018 | $477,000 | -33.8% | 113,485 | -1.4% | 0.22% | -18.1% |
| Q3 2018 | $721,000 | -28.3% | 115,115 | -8.0% | 0.26% | -25.6% |
| Q2 2018 | $1,006,000 | +7.8% | 125,115 | 0.0% | 0.36% | +4.7% |
| Q1 2018 | $933,000 | +16.0% | 125,115 | -7.4% | 0.34% | +16.8% |
| Q4 2017 | $804,000 | -24.7% | 135,115 | -6.9% | 0.29% | -29.7% |
| Q3 2017 | $1,068,000 | +8.4% | 145,115 | 0.0% | 0.41% | +3.2% |
| Q2 2017 | $985,000 | -2.7% | 145,115 | +35.4% | 0.40% | -9.5% |
| Q1 2017 | $1,012,000 | +9.3% | 107,200 | 0.0% | 0.44% | +1.8% |
| Q4 2016 | $926,000 | -39.7% | 107,200 | -55.8% | 0.44% | -38.6% |
| Q3 2016 | $1,536,000 | +44.1% | 242,650 | -4.0% | 0.71% | +29.0% |
| Q2 2016 | $1,066,000 | -13.5% | 252,650 | -10.6% | 0.55% | -14.5% |
| Q1 2016 | $1,232,000 | -31.0% | 282,650 | -2.9% | 0.64% | -30.1% |
| Q4 2015 | $1,785,000 | +7.2% | 291,150 | 0.0% | 0.92% | -0.8% |
| Q3 2015 | $1,665,000 | -23.3% | 291,150 | 0.0% | 0.92% | -10.8% |
| Q2 2015 | $2,172,000 | +24.8% | 291,150 | 0.0% | 1.04% | +25.4% |
| Q1 2015 | $1,741,000 | – | 291,150 | – | 0.83% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVERENCE CAPITAL MANAGEMENT INC | 28,980 | $123,000 | 0.01% |
| Daiwa Securities Group Inc. | 533 | $2,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 138,663 | $52,000 | 0.00% |